Anti-Human TNFRSF14 (NT)

Anti-Human TNFRSF14 (NT)

Product No.: T311

[product_table name="All Top" skus="T311"]

- -
- -
Target
TNFRSF14
Product Type
Polyclonal Antibody
Alternate Names
Tumor Necrosis Factor Receptor Superfamily Member 14, Herpesvirus Entry Mediator (HVEM), TR2, ATAR, HVEA, LIGHTR
Applications
IHC FFPE
,
WB

- -
- -
Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human Tumor Necrosis Factor Receptor Superfamily Member 14 (TNFRSF14) recognizes Human TNFRSF14. This polyclonal antibody was purified using affinity chromatography.
Background
Tumor necrosis factor receptor superfamily member 14 (herpesvirus entry mediator), also known as TNFRSF14, is the cellular receptor for TNF superfamily 14 (LIGHT).1 TNFRSF14 is a type I membrane protein that is considered as a Herpesvirus entry mediator.2 It is able to inhibit the proliferation, activation, and cytokine production of T cells. TNFRSF14 is expressed by peripheral blood T cells, B cells, monocytes and in various tissues enriched in lymphoid cells.

Antigen Details

PubMed

References & Citations

1. Park JE et al. (2001) Arterioscler Thromb Vasc Biol. 21: 1873 2. Montgomery RI et al. (1996) Cell 87: 427
IHC FFPE
General Western Blot Protocol
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.